About this trial
This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Self-identify as disabled
Report problems with social participation
Speak English
Live in a community setting
Disqualifiers
Severe communication impairment limiting ability to verbally indicate interest in participation
Trial design
Single group
Treatments tested in this trial
ENGAGE
BehavioralENGAGE is a group intervention designed to improve social participation within the context of the COVID-19 pandemic.
Treatment groups
Trial outcomes
Primary outcomes
Intervention Feasibility
Recruitment (5-7 participants per group recruited within one month), retention (80% of participants complete follow up assessments), adherence (80% of participants complete the intervention group
Intervention Satisfaction
Client Satisfaction Questionnaire-8: 8-item scale of intervention satisfaction with a 32-point scale (higher scores indicate greater satisfaction). We will establish adequate acceptability if we achieve a mean score of 24 or greater.
Secondary outcomes
Social Participation
PROMIS Ability to Participate in Social Roles (Cohen's d=/\> .2)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Illinois at Chicago
Lead sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator